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Foot-and-Mouth Disease Virus (FMDV) is a member of the Picornaviridae family of viruses, 
which includes viruses that cause a number of high consequence human and animal diseases 
in addition to Foot-and-Mouth Disease (FMD), such as hand-foot-and-mouth disease, 
herpangina, polio, and encephalomyocarditis. FMDV infects domestic and wild cloven-hoofed 
animals, including bovine, caprine, ovine and swine species that are vital to the livestock 
industry.  Depending on host and virus characteristics, FMD exhibits a broad range of clinical 
presentations resulting in significant morbidity. Generally, FMD produces fever and soreness, 
excessive salivation, loss of appetite and large vesicles on the feet, nose and tongue 24 to 72 
hours post-infection (hpi). In some cases, complete prostration accompanied by the loss of 
hooves occurs (for review see refs. 1-4). Although mortality rates are typically low and usually 
associated with young or immunocompromised animals, the economic consequences of an 
FMD outbreak, such as dramatic decreases in livestock productivity and banning of the export 
of animals and animal products, are so significant that FMD is one of the most threatening 
diseases of domestic animals in the world. In many developing regions of Asia, Africa and 
South America, FMD is enzootic. Global economic activities and transboundary movement of 
people and animals presents a significant risk of accidental introduction of FMDV into 
previously FMDV-free countries. Additionally, terrorist groups may intentionally introduce 
FMDV into a country that is FMD-free and does not vaccinate against the virus (refs.5-8 and 
http://www.oie.int; http://iah.bbsrc.ac.uk/virus/Picornaviridae/Aphtovirus/fmd.htm ). 
2. Foot-and-mouth disease virus 
Like all picornaviruses, FMDV is a non-enveloped virus with icosahedral symmetry and 
contains a single-stranded, positive-sense RNA molecule of approximately 8500 nucleotides 
(nt). The viral particle is small in size (approximately 30 nm diameter) and is composed of 60 
copies each of proteins 1A, 1B, 1C and 1D (also known as VP4, VP2, VP3 and VP1, 
respectively) assembled in groups of increasing complexity. A single cluster of structural 
proteins, known as the protomer, involves one copy each of 1A, 1B, 1C and 1D.  Five 
protomers assemble together to form a pentamer, which are then assembled into groups of 
twelve to form the complete viral capsid (9, 10). 
FMDV RNA possesses genetic characteristics, such as positive polarity and a 
polyadenylated 3’ end, that allows it to act as messenger RNA (mRNA) in vitro and in vivo, 
and therefore should be considered a potentially infectious agent. RNA extracted from field 
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samples has been used to produce infectious viruses using in vitro cell electroporation 
techniques. The rescued viruses were highly pathogenic in natural hosts and could be 
characterized using ELISA and full genome sequencing. This feature of the FMDV genome 
allows for manipulation of cDNA copies to study the genetics of pathogenesis and observe 
the phenotypic effects of mutations and other genomic alterations. This application of 
“reverse genetics” to construct chimeric and recombinant FMDVs has led to the discovery of 
several determinants of viral replication, host recognition and virulence (3, 4, 11).  
Continued use of reverse genetics will enhance current models of FMDV pathogenesis and 
further progress towards therapies and vaccines. 
3. FMDV genomics publications 
Analyses have been performed on the complete P1 polyprotein, the genomic region 
encoding all four structural proteins that compose the viral capsid (1A, 1B, 1C and 1D). 
However, most of the work published regarding FMDV genomics is limited to the coding 
region of capsid protein 1D (also known as VP1). This information has been used to analyze 
variability, selective pressures and immunogenicity of FMDV. Phylogenetic analysis 
employing 1D sequences and a 15% nucleotide difference as a cut-off organizes FMDV 
strains into major groups or genotypes. Interestingly, the genotypic information obtained 
with approximately 636 nucleotides of VP1 completely matches the phylogenetic results 
obtained when 2208 nucleotides of the complete P1 polyprotein are used (12, 13).  Genetic 
lineages subsequently are geographically bound and are described as “topotypes”. The viral 
capsid, notably the 1D protein, harbors immunogenic epitopes that are critical for 
neutralization of the virus. Hence, the topotype classification system has extraordinary 
value for vaccine selection.  
The development of high-throughput sequencing techniques has allowed for complete 
genome sequencing of FMDV, significantly improving our understanding of infection, host 
range, and transmission. The use of complete FMDV genome sequences in phylogenetic 
studies has revealed much more complex epidemiological relationships between isolates 
than previously thought. Full genome comparisons suggest that the epidemiology of FMDV 
is heavily impacted by recombination; it also has led to the discovery of novel genetic 
lineages containing genomic sequences that appear equally distant from SAT and 
Euroasiatic lineages of the virus.  Furthermore, complete genome sequencing has enhanced 
the discovery of FMDV variability, sequence conservation and universal genetic motifs that 
affect its virulence and transmission. Complete genome sequence analysis of FMDV isolates 
collected during the August 2007 outbreaks in England identified the initial and 
intermediate sources of the outbreaks, demonstrating the value of complete sequence 
analysis when examining virus phylogeny, an accomplishment previously impossible using 
partial genomic sequences (14, 15, 16).  
4. Genome structure and proteins 
4.1 FMDV genome 
Upon entrance into the host cell the virus particle dissociates and the RNA is released into 
the cytoplasm. The genome of picornaviruses functions as a messenger (+) RNA, 
polyadenylated at its 3’-end and covalently linked to a small protein (VPg) at its 5’-end. 
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Translation occurs as a single polypeptide precursor (ORF) that is cleaved into functional 
proteins, mostly by virally encoded proteases (3, 10, 17).  
Primary processing of the FMDV ORF results in three large intermediate polyproteins 
(L/P1, P2 and P3). Protease cleavage by FMDV proteins L, 3C and 2A produces smaller sub-
products and 12 final mature proteins: L, 1A, 1B, 1C, 1D, 2A, 2B, 2C, 3A, 3B, 3C and 3D 
(Figs. 1 and 2). As mentioned above, 1A, 1B, 1C and 1D are the structural proteins that form 
the viral capsid. FMDV 2B and 2C proteins localize to ER-derived vesicles, the site of viral 
replication, but their functions remain poorly understood. 3A is thought to be a 
multifunctional integral membrane protein that enhances viral RNA synthesis and exhibits 
host-related markers. Unique to FMDV are three non-identical copies of the genome-linked 
3B, a protein required for viral RNA replication. Finally, 3D encodes the viral RNA-




Fig. 1. FMDV RNA genome representation with detailed description of the UTR elements 
and its predicted secondary structure: (I) S-fragment; (II) IRES; (III) 3’ NCR. Also includes a 
graphic representation of the distribution of variability within the complete coding region 
(ORF), expressed as rate of substitutions per nucleotide site of a Clustal W multiple 
alignment of all serotype FMDV full length genomes (ref 14 for more detailed view). 
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The nomenclature used for FMDV proteins is similar amongst all picornaviruses and is 
based on their position in the viral RNA genome (18). However, it does not imply a 
conserved function of the proteins across all genera. In fact, there is increasing evidence that 
despite sharing similar genome organization and protein names there can be significant 
differences in functionality. For instance, FMDV encodes a 3A protein that is 50% longer 
than the equivalent protein encoded by poliovirus; FMDV also harbors three copies of 3B in 
contrast to a single copy in poliovirus. Additionally, the role of the poliovirus 3A protein in 
immune evasion and persistent infection seems to be played by FMDV 2BC . 
Traditionally, the FMDV genome is classified into coding (ORF) and non-coding regions 
(NCRs) that distribute along three defined genomic intervals: (i) the 5’ untranslated region 
(5’-UTR), which contains non-coding nucleic acids that carry many regulatory elements; (ii) 
the protein coding region (ORF), which includes both structural and non-structural proteins; 
and (iii) the 3’ UTR or non-coding region, which also carries regulatory functions and a 
poly(A tail.  
4.2 FMDV 5’ UTR 
The 5’-UTR of FMDV is unusually long and highly variable, both in length and nucleotide 
composition. It includes a number of structural and functional elements that are critical for 
the replication and biology of the virus (17, 19, 20). The role(s) of many FMDV RNA 
domains in the 5’ UTR are poorly understood, but several have been analyzed and are 
described herein. Ordered from the 5’-terminus of the molecule (Fig. 1), the following 
regions have been defined: 
A highly structured small fragment or “S-fragment” of about 370 residues of unclear 
function. Evidence suggests that the S-fragment has a critical role during RNA replication 
(Fig. 1-I). 
An internal polyribocytidylic, or poly(C), tract of 100 to 400 nucleotides, comprised 
predominantly of cytosine residues. Unusual among picornaviruses, it has been described as 
an element related to virulence, but subsequent studies using infectious clones (ICs) suggest 
the contrary. Its biological function is not well understood (21). 
A pseudoknot region, also of unknown function and variable length. This region contains 
significant deletions in some FMDV isolates, and its presence has never been linked to any 
specific biological function. 
A cis-Replicating Element (cre) or 3B-uridylylation site (bus), conforms of a stem-loop 
structure containing a conserved AAACA motif, functions as a template for addition of U 
residues to the protein primer 3B. It is critical during transcription in order for 
circularization of the viral RNA to occur (22).  
A type-2 IRES of about 440 nt, comprised of five major domains, H-L (Fig 1-II). The IRES 
facilitates the internal initiation of protein synthesis in a CAP-independent fashion, allowing 
it to mediate ribosome recruitment to an internal site within the viral RNA (23). This process 
is facilitated by eukaryotic translation initiation factors (eIFs). Initiation of translation by the 
IRES begins with specific binding of the central domain initiation factor, eIF4G, to the J-K 
domains, which is stimulated by eIF4A. Then, these initiation factors induce a 
restructuration of the region and promote recruitment of ribosomal pre-initiation 
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complexes. PTB and ITAF45 trans-acting factors are also required to stabilize the active 
conformation. Both binding of eIF4G to the IRES and IRES-directed translation are 
significantly impaired by mutations that impact the integrity of the double-stranded 
secondary structure. In fact, the primary sequence within the IRES of different FMDV 
isolates can be up to 50% variable and still retain similar overall secondary structure using 
compensatory base changes in helical elements.   
4.3 FMDV coding region (ORF) 
Protein synthesis starts at one of two functional in-frame AUG codons, separated from each 
other by an indispensable but highly variable tract of approximately 80 to 84 nucleotides. 
The long ORF that follows the AUG codon encodes a polyprotein of about 2330 amino acids 
(aa), although length and composition among natural isolates and even among passaged 
viruses can be variable. Although the polyprotein intermediaries of processing are 
biologically important, the current discussion will concentrate only on the twelve final 
protein products. For a complete review of cleavage sites, biologically critical residues, and 
variability/conservation between serotypes, see ref. 3, 4, 18.  
Components of the polyprotein, from 5’ to 3’ (Fig. 2): 
 
Fig. 2. Upper panel: schematic representation of FMDV genome and poly-protein coding 
region including protein-encoding regions, cleavage intermediates and mature protein 
products. Lower panel: schematic representation of the non-synonymous (amino acid) 
substitutions per site within the whole poly-protein (ORF). 
4.3.1 Leader protease (Lpro) 
Two in-frame AUG codons allow for two different initiation events within Lpro, producing 
two forms of the protein, named Lab and Lb. Both proteins catalyze their own cleavage at 
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their C-terminus from the rest of the polyprotein as well as cleavage of the initiation factor 
eIF4G (p220) of the CAP-binding complex eIF4F, contributing to the shut-off of host cell 
protein synthesis. Approximately one-third of cell ribosomes initiate at the first AUG 
(AUG1, of Lab) site, while the majority of ribosomes start translation at the second AUG 
codon (AUG2, of Lb). It is unknown why ribosomal preference for the second AUG exists. 
Both proteins also limit the host innate immune response via inhibition of interferon beta 
(IFN-β) mRNA expression. L(pro) localizes to the nucleus of infected cells and disrupts the 
integrity of the nuclear factor NF-κβ using mechanisms that antagonize the cellular innate 
immune and inflammatory responses to FMDV infection. 
4.3.2 P1 coding region 
The P1 polypeptide sequence begins immediately downstream of the Lpro protein. Included 
within P1 are the four capsid proteins: 1A, 1B, 1C, and 1D (also known as VP4, VP2, VP3, 
and VP1, respectively). With the exception of 1A, which is excluded from the virion surface, 
capsid proteins (1B, 1C and 1D) are involved in antigenicity and binding to a subset of RGD-
dependent integrins and heparin sulfate proteoglycan receptors on the cell surface 
(reviewed in Ref.  24). 
FMDV structural proteins are involved in capsid assembly and stability, virus binding and 
antigenicity. Despite these essential characteristics, there is a high degree of flexibility in the 
primary sequence of most of these proteins. The structural proteins exhibit the highest rates 
of nucleotide and amino acid (aa) variability among all viral proteins, likely a response to 
intense selective pressures. VP4 is an exception to this observation, since 73% to 84% of its 
nucleotide sequence is conserved among all FMDV isolates.  
The only internal capsid protein, 1A, carries a swine-specific immunodominant and 
heterotypic T-cell antigenic site that is capable of providing help to a B-cell epitope when in 
tandem. Within the amino half of 1A, a conserved myristate binding site exists.  
Structural protein 1B, or VP2, plays a critical role in capsid stability and particle maturation, 
supported by the observation that 47% of its amino acids are invariant between and among 
different FMDV serotypes. At least 3 T-cell epitopes have been identified within 1B, 
exemplifying its immunogenicity. A number of important conformational neutralizing 
epitopes and one T-cell epitope have also been identified in protein 1C (VP3).  
The best known FMDV protein is 1D, also known as VP1. VP1 is the most variable region of 
the FMDV genome; only 26% of its aa are universally conserved between serotypes. Many of 
the residues known or suspected to be critical for cleavage or other functions are located 
within invariant sequence motifs, indicating that the critical function of those residues may 
be contextual and require other specific residues. Protein 1D is responsible for virus 
attachment and entry, protective immunity and serotype specificity. A major, non-essential 
immunodominant site is located within the so-called G–H loop of VP1. This loop appears 
highly disordered in X-ray diffraction patterns of crystallized virions, but it is known to 
protrude from the capsid surface when the capsid is bound to an antigen-binding fragment 
(Fab). After binding of a cellular integrin receptor to the RGD motif in 1D, FMDV utilizes 
endocytosis to infect the cell. Viral replication commences when the viral capsid dissolves, 
allowing the release of RNA into the cell cytoplasm. Viruses that have sequences similar to 
the RGD motif can infect cells via different integrin receptors and can induce disease and 
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transmission to susceptible animals. Other critical aa residues have been identified, such as 
the methionine (Met) at position 54, whose change to isoleucine (Ile) affects processing of 
precursor P1, decreasing production of VP1 and accumulation of VP1 precursor proteins. 
Although not in direct contact with the VP1-VP3 cleavage site, residue M54 of VP1 is 
exposed at the virion surface and it is close to an antigenic site within the B-C loop. Residues 
within the 1AB cleavage pocket and a 1C histidine (His-142-alpha-helix charge-dipole 
interaction at the twofold axes of symmetry between pentamers) play a role in acid-induced 
disassembly of the capsid. 
4.3.3 P2 coding region 
Most of the non-structural proteins (NSPs) are found within the P2 and P3 coding regions. 
These polypeptides and mature proteins are involved in RNA replication and viral 
maturation, although their specific roles remain to be elucidated. FMDV 2A is an 18 aa 
peptide that induces P1/2A polypeptide release from the rest of the genome through 
modification of the cellular translation apparatus. Generating the C-terminus of 2A and the 
N-terminus of 2B does not involve a protease, but rather cleavage of the ester linkage of 
peptidyl-tRNA within the peptidyl-transferase center of the ribosome during translation, a 
phenomenon termed 'StopGo'. The functional motif of 2A resides in a highly conserved aa 
sequence in its carboxy-terminal portion. This co-translational dissociation of the 
polyprotein and immediate recovery has been widely applied to develop research tools and 
gene therapies. The 2A protein is released from P1 by cleavage with the 3C viral protease in 
a later stage of processing. However, its function as an independent protein is not yet 
understood.  
Little is known about the function of the FMDV 2B protein. It is a small hydrophobic protein 
that, upon individual expression, is localized to the endoplasmic reticulum (ER) and the 
Golgi complex. Differing from other picornaviral 2B proteins, FMDV 2B has minimal effects 
on Ca(2+) homeostasis and intracellular protein trafficking. However, it does cause 
accumulation of ER proteins in large vesicular structures around the nucleus. A trans-
membrane domain has been predicted between aa positions 120 and 140, supporting its 
involvement in vesicles and membrane-related stages of viral infection. Its expression in 
cells enhances membrane permeability and has been implicated in cytopathic effect. Only 37 
of the 154 aa that compose the 2B protein are variable, and even those are restricted to one 
or two possible aa’s, illustrating the great constriction of 2B protein variability. 
Protein 2C is a highly conserved peptide with ATPase and RNA binding activity that is 
318 aa in length. It has been assigned to the SF3 helicase family of AAA+ ATPases. In 
infected cells 2C is involved in the formation of membrane vesicles where it co-localizes 
with viral RNA replication complexes. Its 18 nt ATP-GTP binding motif is highly 
conserved in all serotypes. This sequence motif is generally referred to as the “A” 
consensus sequence or the P-loop, and is found in many protein families, such as 
thymidine kinases, ATP-binding proteins involved in active transport, DNA and RNA 
helicases, etc..  Protein 2C is involved in RNA synthesis and is the site of mutations that 
confer resistance to guanidine hydrochloride. Substitution of arginine 55 to tryptophan 
(R55W) within 2C mediates an increase in the extracellular release of viral RNA without a 
detectable increase of total viral RNA.  
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4.3.4 P3 coding region 
FMDV protein 3A is a membrane-associated protein that localizes to a reticular structure. 
Some studies suggest that 3A influences host-range; for example, the amino acid 
substitution glutamine 44 to arginine (Q44R) in 3A, either alone or in combination with the 
replacement of isoleucine 248 with threonine (I248T) in 2C, was sufficient to give FMDV the 
ability to produce lesions in guinea pigs.  Also, a 10 aa deletion and a series of substitutions 
(accumulated over the following 29 years) that surround the deletion were described to be a 
primary determinant of restricted growth of O/Taiwan 97 on bovine cells in vitro and as a 
contributor to bovine attenuation of O/Taiwan 97 in vivo. Subsequent experiments 
demonstrated that this deletion on its own does not contribute to porcine tropism of the 
virus, but that genome-wide changes (in addition to the deletion) produce the porcinophilic 
phenotype of current Asian viruses within this lineage.  
The 3B region codes for 3 non-identical copies of the VPg protein. Covalent linkage of VPg 
occurs via a tyrosine (Y) residue to the 5’ end of the positive-sense RNA viral genome and to 
the nascent viral plus- and minus-stranded RNAs. This protein serves as a primer for the 
initiation of RNA replication and plays a role as an encapsidation signal. This priming step 
requires uridylation of the VPg peptide by the viral polymerase 3D and other viral or host 
cofactors. It remains to be elucidated why FMDV is the only picornavirus that encodes 3 
tandem repeats of the VPg protein within the 3B coding region. Limited studies suggest it 
may be a critical component of the viral replication complex, enhancing transcription 
efficiency of the viral genome. Engineered FMDV infectious clones with either severe 
domain disruption or deletion of individual 3B proteins do not exhibit decreased infectivity 
in vitro, nor do they alter clinical disease in cattle or swine. Only clones encoding a single 
copy of VPg seem impaired in replicative competence. Interestingly, these mutant FMDVs 
did not produce plaques in BHK-21 tissue culture but produced a mild disease in swine and 
cattle.   
The viral proteinase, 3Cpro, is a serine protease that catalyzes ten of the thirteen cleavages 
necessary to complete FMDV polyprotein processing.  Its protease activity also affects host 
cell transcription since 3Cpro is responsible for the cleavage of the cellular histone H3 as 
well as the elongation factors eIF4G and eIF4A, resulting in cessation of host cell 
transcription. Crystal structure analyses indicate that FMDV 3Cpro adopts a chymotrypsin-
like fold in the characteristic fingers, palm and thumb subdomains, with the presence of an 
NH2-terminal segment encircling the active site. The necessity of this tridimensional 
structure imposes serious restrictions on amino acid variability. 
Replication of the RNA genome of the virus, via negative strand intermediates, involves an 
RNA-dependent RNA polymerase, 3Dpol. Several specific aa’s have been determined as 
essential for maintaining the functional integrity of the polymerase. A NTP-binding motif 
and hydrophobic antigenic regions have also been described within 3Dpol. 
4.4 FMDV 3’ UTR 
The 3' end of foot-and-mouth disease virus is required for viral infectivity and stimulates 
IRES activity. It is composed of two distinct elements: a 90 nt untranslated region (3'-NCR), 
and a poly(A) tract. The 3'-NCR has a highly conserved structure composed of two stem-
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loops (SL-1 and SL-2) that interact with viral and host proteins during RNA replication. The 
poly(A) tract is generally heterogeneous in length and has an important structural role 
during replication. Independent deletions within the two predicted stem-loop structures of 
the 3'-NCR have provided information about potential functions. Deletion of SL2 was lethal 
for viral infectivity in vitro, while removal of SL1 negatively impacted viral growth kinetics 
and impaired negative-strand RNA synthesis, down-regulating genome replication. Studies 
examining the in vivo phenotype of these mutant viruses in pigs suggest that deletion of SL1 
may contribute to FMDV attenuation, supporting the potential of RNA technology for the 
design of new FMDV vaccines. The 3' end of FMDV RNA establishes two distinct strand-
specific, long-range RNA-RNA interactions: one with the S region and another with the 
IRES element. The S region interacts with each of the stem-loops, and such interaction is 
dependent of the poly(A) conformation.  
5. FMDV cell entry and genome replication 
FMDV initiates infection by binding to integrin receptors via an Arg-Gly-Asp (RGD) 
sequence found in the G-H loop of the structural protein VP1. The particle dissociates into 
pentamers at mildly acidic pH and the RNA is liberated into the cytoplasm of the infected 
cell. FMDV uses standard picornavirus cell entry mechanisms, forming 'altered' particle 
intermediates thought to induce membrane pores through which the genome can be 
transferred across the endosome membrane. Induction of viral RNA translation and 
cessation of cellular RNA translation occurs concurrently. The synthesis of cellular proteins 
is prevented by viral proteases that cleave cellular elongation factors, inhibiting  CAP-
dependent translation. The viral proteins required for replication are immediately obtained 
from translation of the positive-sense viral RNA. These proteins also synthesize negative-
sense transcripts based on the positive-sense RNA template. The negative-sense RNA then 
becomes the template used to synthesize di novo positive-sense viral genomes (24). Anti-
sense RNA is found at a one hundred-fold less concentration than sense strands in infected 
cells, suggesting that each negative-sense strand may serve as template for the synthesis of 
many positive-sense strands. Genome copying occurs via a complementary negative-sense 
RNA template and the formation of two replicating positive-sense strands. Partially double-
stranded replicative intermediates may also be involved (review in ref. 22-24).  
FMDV RNA replication is initiated by the covalent attachment of an uracil monophospate 
(UMP) molecule to the hydroxyl group of a tyrosine within the terminal VPg protein. This 
reaction is catalyzed by the virally encoded RNA-dependent RNA polymerase, 3D. The 
enzyme performs this operation, together with other viral and probably host proteins, in 
the cytoplasm of the host cell. Cytoplasmic RNA Helicase A (RHA) plays an essential role 
during replication of FMDV, interacting with the S fragment and the viral 2C and 3A 
proteins, as well as with cellular PABP, promoting the assembly of ribo-nucleoprotein 
replication complexes at the 5' end of the genome. Eukaryotic initiation factors (eIFs) are 
required for internal translation initiation at the internal ribosome entry site (IRES), an 
action common to all picornaviruses. The eIF4B is an RNA-binding protein that stimulates 
the ATPase and helicase activities of eIF4A and strengthens the mRNA-rRNA-tRNA 
interactions at the initiation codon. The eIF4A is an ATP-dependent RNA helicase; it is 
believed to unwind RNA secondary structure and is the prototypic member of the DEAD 
box family of helicases. The eIF4B is present both as part of the eIF4F complex bound to 
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eIF4G, and also free in the cytoplasm. The helicase activity of eIF4A is strongly stimulated 
by eIF4B. The cleavage of eIF4G releases the N-terminal domain that contains the binding 
sites for eIF4E and the poly(A) binding protein. The residual portion of eIF4G, which is 
sufficient for IRES-directed translation, retains two binding sites for eIF4A and binding 
sites for eIF3 and Mnk-1. Thus eIF4G is a bridge between the mRNA and small ribosomal 
subunit. The eIF4B is incorporated into ribosomal 48S initiation complexes via the FMDV 
IRES. In contrast to the weak interaction of eIF4B with capped cellular mRNAs and its 
release upon entry of the ribosomal 60S subunit, eIF4B remains tightly associated with the 
FMDV IRES during formation of complete 80S ribosomes. Binding of eIF4B to the IRES is 
energy dependent, and binding of the small ribosomal subunit to the IRES requires the 
previous energy-dependent association of initiation factors with the IRES. The interaction 
of eIF4B with the IRES in 48S and 80S complexes is independent of the location of the 
initiator AUG and thus independent of the mechanism by which the small ribosomal 
subunit is placed at the actual start codon, either by direct internal ribosomal entry or by 
scanning.  
Final assembly of the viral capsid and encapsidation of the viral RNA occur by mechanisms 
that are still obscure. Two hypotheses describe potential mechanisms of pentamer assembly 
into pro-virions. One idea postulates that the RNA is inserted into the virion after assembly 
of the capsid, while the other theory proposes that the viral RNA interacts directly with the 
pentamers to form the pro-virion prior to capsid formation. 
6. Genetic variability of FMDV RNA 
Due to the absence of proofreading-repair activity by the viral replicase, FMDV RNA 
genome replication is highly error-prone. The high mutation rates result in populations that 
consist of genetically related but non-identical viruses known as quasispecies. The quasispecies 
concept maintains that a viral population consists of a ‘swarm’ of genetic and phenotypic 
variants in perpetual renewal as genome replication proceeds in an infected host. The 
consensus nucleotide sequence of FMDV isolated from a clinical sample derives from a 
multimodal population of similar but distinct viruses; often the exact consensus sequence 
obtained does not exist within the population, but is a reflection of many co-existing 
quasispecies. The existence of quasispecies populations may explain the dramatic genetic 
plasticity observed in disease-causing RNA viruses, supporting pathogenic adaptations that 
expand their host repertoire and virulence profile (Review in Ref. 26-29).  
Several in vivo experiments report the generation of highly variable FMD viruses from single 
animals during infection studies. These observations may have been influenced by 
molecular host factors and/or selective pressures indirectly incurred from lab 
methodologies (see ref. 28-32). However, additional controlled experimental infections in 
pigs confirmed these observations in every passage of in vivo infection. Interestingly, the 
location and nature of the genetic variation was not the same as in vitro-acquired differences 
(see ref. 31, 32, 33, 34, 37), including the estimated number of substitutions per nucleotide. 
Recently, a study conducted during the United Kingdom 2001 epidemic demonstrated that 
nucleotide changes occur throughout the genome at a rate of 2.26 x 10-5 nucleotide 
substitutions per site per day (95% confidence interval [CI], 1.75 x 10-5 to 2.80 x 10-5) and 
nucleotide substitutions accumulate in the consensus nucleotide sequence at an average rate 
of 1.5 substitutions per farm infection. Data obtained from outbreaks like the 2001 epidemic 
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support the experimental observations, demonstrating the role of host-related selective 
pressures on the variability and evolution of FMDV (35). 
Comparative genomics studies using full-length sequences representative of all seven 
serotypes have identified highly conserved genomic regions, indicating functional 
constraints for variability as well as as-yet undefined motifs with likely biological 
significance (14, 34). At least 64% of all nt sites within the FMDV genome are susceptible to 
substitution, including compensatory substitutions. It is important to clarify that most of the 
“variant” or substitutable residues within the FMDV genome mutate in response to 
detrimental effects produced by mutations elsewhere in the genome. But most importantly, 
it indicates that at least 46% of the nucleotides are indispensable for FMDV survival; 
replacement of any of the known critical residues renders non-viable progeny. 
In support of the comparative genomics analyses, sequence studies demonstrate that the 
most distantly related pair of FMDV isolates to-date do not differ more than 22% from each 
other. Within one serotype the differences are less than 15%. Although sequences have been 
intensely analyzed in terms of similarity and divergence, the genetic bases of most biological 
traits of FMDV remain to be discovered. Such analysis would benefit from initial studies 
examining the conserved regions within the ORF; notably, regions 2B and 3C exhibit the 
highest percentage of invariant nt (61% and 59%, respectively) and amino acids (76%) in the 
genome. 
The most variable parts of the translated FMDV genome, like Lpro, 3A, 3B and the structural 
proteins (1B, 1C, and 1D) suggest that these proteins are subjected to strong selective 
pressures. Additional studies and characterization will reveal important molecular markers 
and signatures of epidemiological and forensic value. This information can be used to 
facilitate development of novel vaccines containing molecular markers that allow for 
differentiation of vaccinated and infected animals.  
7. FMDV RNA recombination and evolution 
Genomic comparisons of full-length sequences have been very useful to the understanding 
of FMDV evolution.  Computer programs have been developed and used to estimate 
various parameters of evolution. The CODEML program is one of most popular, widely 
used to obtain the ω parameter (ω = dN/dS), an indicator of selective pressure that 
considers and compares several models of evolution. For FMDV, CODEML ω rates obtained 
from different substitution models indicated that a few clusters of codons in Lpro, 1D, 3A 
and 3B may undergo diversifying selection. Evidence of positive selection has been 
identified in complete capsid sequences from all serotypes. Results suggest that novel 
antigenic variants benefit from a selective advantage in their interaction with the immune 
system, possibly throughout the course of an infection and/or during transmission to 
individuals with previous exposure to antigen (see ref. 14, 36-38).  
Analysis of amino acid usage at sites under positive selection indicates that this selective 
advantage can be conferred by amino acid substitutions that share physical and chemical 
properties. Besides genetic drift, there is increasing evidence that recombination is an 
important mechanism of FMDV evolution. Using different recombination detection methods 
among the publicly available FMDV complete genome sequences, the large number of 
recombinant isolates suggests that horizontal recombination of sequences is common and 
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probably advantageous in terms of fitness costs. Interestingly, the distribution of 
recombination breakpoints was found to be largely nonrandom (37, 38). Results suggest that 
genome regions encoding the structural proteins are functionally interchangeable modules, 
as can be deduced from evidence that the structural and nonstructural coding regions of 
picornaviruses evolve largely independently of one another (see ref. 14, 37-40).  
Recombinant viruses may derive from an animal that is co-infected with different virus 
variants while also harboring viruses from a previous persistent or sub-clinical infection. 
We are still not very knowledgeable about subclinical and persistent infection. Indications 
of differential susceptibility for developing a subclinical course of disease has been 
observed in many instances: buffaloes and cattle present with different disease 
manifestations, with breed affecting severity (see ref. 41); sub-clinical symptoms in sheep 
variable and goats make detection of FMD difficult in those species (see ref. 42, 43, 44); 
and establishment of persistent infection in ruminants has been demonstrated (see ref. 45). 
Most interestingly, pigs experimentally infected with a highly virulent porcine-tropic 
strain (OTw97) exhibited gradual loss of virulence and the establishment of a subclinical 
infection upon serial passage in the absence of FMDV-specific antibodies (38). However, 
experimental evidence of possible mechanisms of transmission and its effects on the 
FMDV genome are sparse; additional controlled experimentation in this field is required 
(32, 33, 38).  
The initial size of a virus population strongly influences evolution and replication fitness. 
While in vitro large population passages often result in fitness gains, repeated plaque-to-
plaque transfers result in average fitness losses, known as Muller’s Ratchet effect. On the 
contrary, experimental infection of a natural host with FMDV seems to require a relatively 
low number of FMDV particles to produce clinical disease. In vivo studies suggest that 
horizontal transmission of FMDV may be achieved with a low number of infectious 
particles. In this scenario, recombination events may rescue defective genomes (Muller’s 
Ratchet) yielding a significant number of virulent viruses that spread into new hosts. In this 
manner, FMDV perpetuates within and between natural hosts and reservoirs, recovering the 
replicative capability of previously defective particles.   
Additionally, recombination within the non-structural genome regions, potentially 
modifying the virulence of the virus, may be involved in the success of the new sub-lineage 
to regain infectiousness. It can also explain why phylogenetic analyses restricted to VP1 
sequences appear to represent evolutionary cul-de-sacs and why they often reveal re-
emergence of previously extinguished VP1 genetic lineages. 
Recombination might be a decisive factor in the production of escape variants. Strong 
immunity includes multiple B-cell and T-cell epitopes that produce efficient humoral and 
cellular immune responses. Such an ample response is obtained after recovery of natural 
infection but is difficult to obtain as the immune response evoked by vaccination. Both B 
and T-cell epitopes have been identified in structural and non-structural proteins of 
FMDV. Some are highly conserved, but others are highly variable. Therefore, it is possible 
that re-arrangement of the antigenic display is one of the mechanisms to escape host 
immune response for FMDV, and that recombination is one major player in such re-
arrangement of antigenic markers. 
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8. Final remarks 
i. A new vaccine generation marked and targeting systemic and mucosal immunity is 
urgently needed for FMDV global eradication plans. Control of FMD is based on two 
major strategies: the slaughtering of affected and contact animals (the so called 
‘stamping out’ procedure) or the regular vaccination of the major host species for 
FMDV. Unfortunately, classical vaccines cannot prevent the establishment of persistent 
FMDV infection in cattle. As an alternative to the conventional inactivated vaccines, the 
use of attenuated antigenically marked virus able to induce a solid and durable 
immunity through replication in the animal is highly desirable. FMDV escapes from 
vaccine production plants or diagnostic and research facilities, like what happen in UK 
2007 ( O1BFS 1860/UK/67) highlight the need for an alternative to the handling of large 
amounts of virus because of the danger of virus escaping from vaccine factories. Also, 
classical, inactivated whole-virus vaccines may be at the origin of outbreaks if 
inactivation prior to vaccine formulation was not complete. There is good evidence that 
some FMD outbreaks probably had a vaccine origin. All these are powerful arguments 
to design vaccines that do not require infectious virus at any stage of their preparation. 
However, to achieve this goal a deep understanding of the molecular bases that govern 
biological and immunological properties of FMDV is necessary. The prediction of viral 
cross-protection remains an important unsolved problem, transcripts that can be 
blocked at some steps of virus replication or assembly, genetic complementation and 
molecular basis of virulence factors should all be deeply explored from the genomic 
knowledge. 
ii. Co-circulation of different types of FMDV is a reality in most parts of the endemic 
regions which represents a serious complication in the epidemiology of FMDV. Global 
epidemiological analysis is vital for implementing progressive regional foot-and-mouth 
disease control programs, but better knowledge of variability, recombination and 
evolution of FMDV is necessary. Development of spatial epidemic models to simulate 
transmission or to assess biosecurity planning and emergency-response preparedness 
requires better knowledge of FMDV evolution. Thus, to really understand FMD field 
epidemiology and how to contain the spreading of new outbreaks, wider molecular 
epidemiology analyses using full length genome information are necessary.  
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